XTLB · Xtl Biopharmaceuticals Ltd · Documents
Market Cap
$6.29M
Shares
2.46M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-05 | — | |
| 6-K | 2026-07-21 | — | |
| 6-K | 2026-06-30 | — | |
| 20-F | 2026-06-30 | 2025-12-31 | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-23 | 2026-06-22 | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-15 | — | |
| 6-K | 2026-05-07 | — | |
| 6-K | 2026-04-29 | — | |
| 6-K | 2026-03-20 | — | |
| 6-K | 2026-03-10 | — | |
| 6-K | 2026-02-27 | — | |
| 6-K | 2026-02-24 | — | |
| 6-K | 2026-02-23 | — | |
| 6-K | 2026-02-17 | — | |
| 6-K | 2026-01-28 | — | |
| 6-K | 2026-01-23 | — | |
| 6-K | 2026-01-23 | — | |
| 6-K | 2026-01-13 | — | |
| 6-K | 2026-01-13 | — | |
| 6-K | 2025-12-30 | — | |
| 6-K | 2025-12-29 | — | |
| 6-K | 2025-12-12 | — | |
| 6-K | 2025-12-05 | — | |
| 6-K | 2025-10-23 | 2025-10-22 | |
| 6-K | 2025-07-28 | — | |
| 6-K | 2025-07-21 | — | |
| 6-K/A | 2025-06-18 | — | |
| 6-K | 2025-06-13 | — | |
| 20-F | 2025-04-30 | 2024-12-31 | |
| 6-K | 2025-04-07 | — | |
| 6-K | 2025-03-04 | — | |
| 6-K | 2025-02-03 | — | |
| 6-K | 2024-12-30 | — | |
| 6-K | 2024-12-30 | — | |
| 6-K | 2024-11-19 | — | |
| 6-K | 2024-11-12 | — | |
| 6-K | 2024-10-15 | — | |
| 6-K | 2024-08-14 | — | |
| 6-K | 2024-07-22 | — | |
| 6-K | 2024-06-12 | 2024-06-11 | |
| 6-K | 2024-06-05 | — | |
| 6-K | 2024-05-13 | — | |
| 20-F | 2024-04-30 | 2023-12-31 | |
| 6-K | 2024-04-30 | — | |
| 6-K | 2024-04-02 | — | |
| 6-K/A | 2024-03-21 | — | |
| 6-K | 2024-03-21 | — | |
| 6-K | 2024-03-20 | — |
Showing 1–50 of 89 filings